Company profile for Hibiskus BioPharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Hibiskus aims to become the selective proteasome inhibitor company by targeting each of the 7 human proteasome catalytic ß subunits with its macrolactam drug candidates. While proteasome inhibition is an established mode of action for FDA-approved drugs, its applications to diseases have been relatively narrow, mostly multiple myeloma, a disorder of antibody-producing cells in the blood. The proteasome is present in all eukar...
Hibiskus aims to become the selective proteasome inhibitor company by targeting each of the 7 human proteasome catalytic ß subunits with its macrolactam drug candidates. While proteasome inhibition is an established mode of action for FDA-approved drugs, its applications to diseases have been relatively narrow, mostly multiple myeloma, a disorder of antibody-producing cells in the blood. The proteasome is present in all eukaryotic cells, so small molecules that selectively target one proteasome among many (and one sub-catalytic activity) have the potential for many pharmaceutical uses.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4717 Campus Dr, Kalamazoo, MI 49008
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty